CP and Wilson disease: Traditionally, Cu status is assessed by measuring serum or plasma total Cu and ceruloplasmin levels (Olivares et al., 2008; Hackler et al., 2020), whereas for WD diagnosis a liver biopsy is required (Mohr and Weiss, 2019).